← Search & browse all drugs
BLOOD AND BLOOD FORMING ORGANS › BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS › I.V. SOLUTION ADDITIVES › Electrolyte solutions
potassium acetate
B05XA17
Forms & Strengths
- Injection: 2 mEq/mL in 2 mL, 5 mL, 10 mL vials
- Injection: 4 mEq/mL in 2 mL, 5 mL, 10 mL vials
Adult Dosing
- Usual dose: 1-2 mEq/kg IV over 1-2 hours, repeated as needed
- Max dose: 200-400 mEq in 24 hours, depending on severity of hypokalemia
Pediatric Dosing
- Neonates (0-1 month): 1-2 mEq/kg IV over 1 hour, repeated as needed
- Infants and children: 1-2 mEq/kg IV over 1-2 hours, repeated as needed
Indications
- Treatment of hypokalemia
- Prevention of hypokalemia in patients at risk
Mechanism of Action
- Replaces potassium ions in the body to restore normal levels
- Helps maintain proper heart rhythm, muscle and nerve function
Contraindications
- Hyperkalemia
- Digitalis toxicity
- Severe renal impairment or renal failure
Adverse Reactions
- Cardiac arrest
- Arrhythmias
- Muscle weakness
- Nausea and vomiting
- Local irritation at injection site
Drug Interactions
- Digitalis: increased risk of digitalis toxicity
- Beta-blockers: increased risk of cardiac arrhythmias
- Other potassium-sparing medications: increased risk of hyperkalemia
Curated Content: Needs Vetting Before Put to Clinical Use